These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Product of the Steel locus can replace leukemic cell interaction. Cáceres-Cortés JR; Hoang T Cancer Res; 1992 Oct; 52(19):5208-12. PubMed ID: 1382839 [TBL] [Abstract][Full Text] [Related]
64. [Differentiation and expression of membrane hemopoietic cytokine receptors on CD34+ bone marrow cells in patients with myelodysplastic syndromes]. Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):234-8. PubMed ID: 21418866 [TBL] [Abstract][Full Text] [Related]
65. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow. Gazzola MV; Collins NH; Tafuri A; Keever CA Exp Hematol; 1992 Feb; 20(2):201-8. PubMed ID: 1371965 [TBL] [Abstract][Full Text] [Related]
66. Low L-selectin (CD62L) expression in acute myeloid leukemia correlates with a bad cytogenetic risk. Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Nuessler V; Schmetzer H Eur J Haematol; 2003 Nov; 71(5):366-76. PubMed ID: 14667200 [TBL] [Abstract][Full Text] [Related]
67. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome. Glinsmann-Gibson B; Spier C; Baier M; Taetle R; Broudy VC; List AF Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248 [TBL] [Abstract][Full Text] [Related]
68. Antigenic phenotype of chronic granulocytic leukaemia progenitor cells in chronic phase and in blastic transformation characterized by means of monoclonal antibodies. Robak T Arch Immunol Ther Exp (Warsz); 1988; 36(4):471-85. PubMed ID: 3074744 [TBL] [Abstract][Full Text] [Related]
69. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis. Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776 [TBL] [Abstract][Full Text] [Related]
70. Role of Granulocyte-Macrophage Colony-Stimulating Factor in Acute Myeloid Leukemia/Myelodysplastic Syndromes. Kassem NM; Ayad AM; El Husseiny NM; El-Demerdash DM; Kassem HA; Mattar MM J Glob Oncol; 2018 Sep; 4():1-6. PubMed ID: 30241179 [TBL] [Abstract][Full Text] [Related]
71. Differential expression of receptors for hemopoietic growth factors on subsets of CD34+ hemopoietic cells. Wognum AW; de Jong MO; Wagemaker G Leuk Lymphoma; 1996 Dec; 24(1-2):11-25. PubMed ID: 9049958 [TBL] [Abstract][Full Text] [Related]
72. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941 [TBL] [Abstract][Full Text] [Related]
73. Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptotic activities. Konopleva M; Mikhail A; Estrov Z; Zhao S; Harris D; Sanchez-Williams G; Kornblau SM; Dong J; Kliche KO; Jiang S; Snodgrass HR; Estey EH; Andreeff M Blood; 1999 Mar; 93(5):1668-76. PubMed ID: 10029596 [TBL] [Abstract][Full Text] [Related]
74. Granulocyte colony-stimulating factor in acute myeloid leukemia. Usuki K; Iki S; Endo M; Kitazume K; Ito K; Watanabe M; Urabe A Stem Cells; 1995 Nov; 13(6):647-54. PubMed ID: 8590866 [TBL] [Abstract][Full Text] [Related]
75. Special Education. Kozutsumi H Oncologist; 1996; 1(1 & 2):116-118. PubMed ID: 10387976 [TBL] [Abstract][Full Text] [Related]
76. Growth factor receptor profile of CD34+ cells in AML and B-lineage ALL and in their normal bone marrow counterparts. De Waele M; Renmans W; Vander Gucht K; Jochmans K; Schots R; Otten J; Trullemans F; Lacor P; Van Riet I Eur J Haematol; 2001 Mar; 66(3):178-87. PubMed ID: 11350486 [TBL] [Abstract][Full Text] [Related]
77. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation. te Boekhorst PA; Löwenberg B; Vlastuin M; Sonneveld P Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839 [TBL] [Abstract][Full Text] [Related]
78. Comparison of megakaryopoiesis in vitro of paired peripheral blood progenitor cells and bone marrow harvested during remission in patients with acute myeloid leukaemia. Briggs M; Adams JA; Brereton ML; Burgess R; Hyde K; Lenehan H; Yin JA Br J Haematol; 2001 Dec; 115(3):563-8. PubMed ID: 11736936 [TBL] [Abstract][Full Text] [Related]
79. Reactivity profiles of leukemic myeloblasts with monoclonal antibodies directed to sialosyl-Le(x) and other lacto-series type 2 chain antigens:absence of reactivity with normal hematopoietic progenitor cells. Muroi K; Suda T; Nojiri H; Ema H; Amemiya Y; Miura Y; Nakauchi H; Singhal A; Hakomori S Blood; 1992 Feb; 79(3):713-9. PubMed ID: 1370643 [TBL] [Abstract][Full Text] [Related]
80. Monoclonal antibodies to the human CSF-1 receptor (c-fms proto-oncogene product) detect epitopes on normal mononuclear phagocytes and on human myeloid leukemic blast cells. Ashmun RA; Look AT; Roberts WM; Roussel MF; Seremetis S; Ohtsuka M; Sherr CJ Blood; 1989 Feb; 73(3):827-37. PubMed ID: 2465043 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]